Skip to main content

Table 2 Median and range of the grouped sub-scores (Voiding and Incontinence) and the individual symptom scores for nocturia, urgency and frequency from the ICIQ LUTS questionnaires (MLUTS and FLUTS for males and females respectively) by treatment, with p-values and standardized effect size, d

From: Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS)

Measure Treatment
A: Placebo B: Melatonin p d
Median Range Median Range
Voiding sub-score 4.0 0–12 2.0 0–12 0.096 0.492
Incontinence (Storage) sub-score 3.0 0–9 3.0 0–12 0.107 0.450
Nocturia 2.0 1–3 2.0 1–3 0.892 0.037
Urgency 2.0 0–3 2.0 1–4 0.772 0.079